Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. 15 July 2019. Christy Wyskiel.

Executive Summary

Liquid biopsy technology is drawing increasing attention from regulators, big manufacturers and investors alike as recent developments in this field show. See what Johns Hopkins's head of technology ventures, Christy Wyskiel, said about it here.

“If this is truly like a cholesterol test, something that some portion of the population has every single year, year-in and year-out, that's tens of millions of tests per year.” Christy Wyskiel, head of technology ventures, Johns Hopkins University 

Click here for a free trial of Medtech Insight

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts